BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, ae...
BioNexus advances VitaGuard Southeast Asia rollout after China hospital visits
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
U.S. stock market midday update: BGLC up 15.88% without positive news? Capital inflow drives volatility
BioNexus Gene Lab | 10-K: FY2025 Revenue: USD 7.425 M
BioNexus Gene Lab 10-K: Revenue $7.42M, EPS $(1.61)
Genflow Biosciences PLC Announces Total Voting Rights